Oncology Models | Charles River Discovery Services

Intratibial Tumor Model 

Charles River has developed intratibial models simulating the disease process to address the challenge of modeling bone lysis and infrequent spontaneous bone metastases. Various cell lines and positive controls as well as combination therapies have been validated in our hands. This model allows for the evaluation of a novel compound's effect on bone lysis or blastic activity.

The study design can incorporate client-driven service additions, including:

  • Treatment efficiency
  • Histopathology
  • Histomorphometry
  • Immunohistochemistry

Distant Metastases in Intratibial Tumor Model Quantified by Histopathology
  Distant Metastases Quantified by Histopathology


The Charles River model provides for:

  • Intratibial injection of tumor cells to induce bone resorption
  • Radiographic quantification of test agents' effects

Data

Chart showing bone density of treated and untreated 13762 rat mammary carcinoma in Fischer 344 rats


13762 Rat Mammary Carcinoma in Fischer 344 Rats

 

For more information about our intratibial tumor model, please contact us at 1.877.CRIVER.1 or askcharlesriver@crl.com.

Discover the full range of Charles River Products and Services
The Source

For more information, contact us at:

1.877.CRIVER.1 (1.877.274.8371)
askcharlesriver@crl.com

view all

News & Events

view all
May 14 - New Models for Evaluating COPD or ...
May 11 - Expert Safety Testing to Accelerat...
Jun 17-Jun 20 -  Noordwijk aan Zee, the Netherlands - 19th MDO Meeting / 12th European ...
Jun 02-Jun 05 - Vancouver, British Columbia - CALAS
Jun 05-Jun 05 - King of Prussia, Pennsylvania - Assessment of Immunomodulation for Biol...
Jun 05-Jun 08 - Saint Germain sur l’Arbresle, France - Charles River LAL Seminar Series
view all
Scientist I Wilmington, MA
Manager International Tax Wilmington, MA

Charles River Laboratories, Inc.